Jugular Venous Sampling
The jugular bulb may be punctured directly by a needle inserted 1 cm below and 1 cm anterior to the mastoid process (1) . Alternatively, an intravascular catheter, similar to those used for central venous pressure monitoring, may be placed retrograde, via the internal jugular vein, into the jugular bulb (13) .
More recently, reflectance oximetry, by using a fiberoptic catheter (see Figure 1 ) in a manner analogous to monitoring of mixed venous oxygen saturation in the pulmonary artery, has allowed for continuous SjVO 2 monitoring (14 -16) . Fiberoptic oximetry is based on the unique light absorption spectrum of oxyhemoglobin. The Baxter-Edwards system (Edslab Sat II, Baxter Edwards Critical Care Division, Irvine, CA) uses two wavelengths of light for reflectance spectrophotometry and is calibrated against a sample of the patient's blood. Conversely, Abbott's system (Opticath Oximetrix, Abbott Critical Care System, Abbott Park, IL) uses three wavelengths of light and may be calibrated in vivo (against the patient's blood) or in vitro (built-in calibration). A SjVO 2 catheter contains two optical fibers. Light is directed into the blood by one of the fibers, reflected back to the second fiber, and transmitted to a photosensor. The photosensor measures the absorption of the reflected light at the various wavelengths with SjVO 2 displayed as a percentage of oxygenated hemoglobin to total hemoglobin. For SjVO 2 catheters using two wavelengths of light, the patient's hemoglobin concentration must be manually entered, with each SjVO 2 value dependent on the validity of the entered value to current conditions. For catheters using three wavelengths, the hemoglobin concentration is calculated from the absorption spectrum, allowing continuous, real-time monitoring of SjVO 2 .
Which Side Should be Monitored?
In patients with bilateral brain injury, the catheter is usually placed in the internal jugular vein on the side of dominant drainage, usually the right (10, 17) . In the presence of a focal brain injury, it is controversial if the catheter should be placed on the side ipsilateral to brain injury or on the dominant side, if different. Stochetti et al. (18) noted that the proportion of headinjured patients with relevant discrepancies of SjVO 2 between the jugular veins is quite high. Fifteen of 32 patients showed oxygen saturation differences Ͼ15% between the two jugular veins, with only 8 patients having consistent differences of Ͻ5%. Beards et al. (9) proposed that asymmetry of Ͼ10%, in SjVO 2 values, occurs 65% of the time.
The dominant side may be determined by comparing the intracranial pressure (ICP) increase caused by manual compression of each internal jugular vein (19) , by computerized tomographic assessment of jugular foramen size (18) , or by ultrasonography to compare internal jugular vein size. The assumption of the compression technique is that a greater ICP increase on one side is the result of occlusion of a larger portion of the cerebral outflow, and therefore more reflective of global conditions. Likewise, the assumption with imaging studies is that there is a correlation between the larger jugular foramen or vein and the dominant side (18) .
Catheter Placement
The central approach, with a puncture sight similar to that used for central venous catheterization, to the internal jugular vein is often used (4,5,20 -22) . However, contrary to central venous catheterization, the needle, guidewire, and catheter are advanced in a cephalad direction. Because of concern for vascular injury to the jugular bulb, the Seldinger guidewire should be J-shaped and only advanced 2-3 cm beyond the needle insertion site, at which point the catheter is advanced until resistance is met at the jugular bulb, usually about 15 cm. At this time, an awake patient may note a sensation in the jaw or ear as the catheter abuts the base of the skull, indicating that the tip of the catheter is in the jugular bulb. The catheter is then pulled back 0.5-1.0 cm so that the catheter does not continue to abut the roof of the jugular bulb and to minimize the cephalad vascular impact with head movement, thereby reducing the risk of vascular injury. Alternatively, an oximetry catheter may be inserted via an introducer to a distance equal to that measured from the point of insertion to the level of the mastoid process (approximately the level of the jugular bulb) or until resistance is met.
Relative contraindications to SjVO 2 monitoring include a cervical spine injury or the presence of a tracheostomy or a coagulopathy. It is important to note that routine maneuvers which aid placement of a catheter inserted via the internal jugular vein, such as Trendelenberg's position or head rotation, may be ill advised in patients with increased ICP or cervical spine injury (21, 23) . Moreover, the internal jugular vein may be absent, occluded, or in an unusual configuration in approximately 10% of patients (24, 25) . Therefore, some clinicians advocate using 2-dimensional ultrasound or a percutaneous needle with Doppler probe (21) to facilitate localization of the internal jugular vein with the patient's head and neck maintained in a neutral position. Complications of SjVO 2 monitoring are uncommon and related to catheter insertion. Complications include carotid artery puncture, pneumothorax, nerve injury, infection, and thrombosis. The concern that a jugular catheter might obstruct venous return and increase ICP appears to be unfounded (26, 27) .
Skull roentgenography can be used to confirm placement (28) . On a lateral neck radiograph, the catheter tip should be at the level of, and just medial to, the mastoid process. Radiography may also detect kinks and confirm that the catheter tip is above the lower border of C1, which reduces the chance of extracranial contamination.
Physiology of SjVO 2 Monitoring
Jugular venous oxygen is an indirect assessment of cerebral oxygen use (see Figure 2) . Simplistically, when demand exceeds supply, the brain extracts greater oxygen, resulting in decreased jugular bulb oxygen saturation. If cerebral blood flow (CBF) decreases, a point is eventually reached at which the brain can no longer completely compensate for decreased CBF by a further increase in oxygen extraction. At this point, oxygen consumption decreases and anaerobic metabolism with lactate production ensues. When cerebral oxygen supply exceeds demand, oxygen saturation of jugular bulb blood is increased.
Cerebral oxygen delivery (DO 2 ) is described by the following equation (CaO 2 ϭ arterial oxygen content): While cerebral oxygen consumption (CMRO 2 ) is described by the equation (CjvO 2 ϭ oxygen content of jugular venous blood):
The difference in oxygen content between arterial and jugular venous blood is expressed by the term (CaO 2 Ϫ CjvO 2 ) or AjvDO 2 . By rearranging the above equation it is apparent that:
Normally, AjvDO 2 is stable at 4 -8 mL O 2 /100 mL blood (29, 30) . If CMRO 2 remains constant, changes in AjvDO 2 should reflect changes in CBF. If AjvDO 2 is Ͻ4 mL O 2 /100 mL blood, it is assumed that oxygen supply is greater than demand (i.e., luxuriant). An AjvO 2 Ͼ8 mL O 2 /100 mL blood suggests that demand is in excess of supply (i.e., ischemia).
If CMRO 2 increases without an increase in CBF, the brain extracts more oxygen from the blood, and there is a decrease in oxygen content or saturation of the venous effluent from the brain (widened AjvDO 2 ). Jugular venous oxygen saturation is normally approximately 55%-75% (1), which is lower than systemic mixed venous oxygen saturation.
If the hemoglobin concentration is stable, the arterial oxygen saturation is approximately 100% and the amount of oxygen dissolved in plasma is physiologic, SjVO 2 is an appropriate correlate of AjvDO 2 . As SjVO 2 is a global measure, SjVO 2 monitoring has high specificity but low sensitivity for ischemia, i.e., a normal saturation may not reflect focal areas of ischemia, but a low saturation is indicative of low flow.
Experimental studies suggest thresholds for jugular venous oxygen values and neurologic change which are summarized in Table 1 . If the SjVO 2 is Ͻ 50%, therapy(s) directed at increasing cerebral oxygen supply and/or decreasing demand should be initiated as detailed in Figure 3 .
Technical/Methodological Limitations
A limiting factor in the acceptance of SjVO 2 monitoring has been a history of relatively poor correlation of concomitant values obtained from cerebral oximetry catheters to an internal jugular venous sample analyzed by a co-oximeter for oxygen saturation (see Table 2 ). The original oximetry catheters were designed for use in the umbilical arteries of neonates. When used in the venous system with nonpulsatile, retrograde flow and a vessel wall that is susceptible to catheter abutment, there have been limitations in the correlation of the online saturation value to oxygen saturation measured by a cooximeter. These concerns, although still present, have been addressed by recent technologic advances (37) (38) (39) .
A second limiting factor concerns the possibility of extracerebral contamination. If blood is sampled at a site within 2 cm of the jugular bulb and at a rate of Ͻ 2 mL/min there is negligible (approximately 3%) extracerebral contamination (6, 40, 41) . A related concern is the observation that, as CBF decreases, the relative extracerebral contribution to a SjVO 2 reading increases. A final technologic issue is the concern of catheter migration and abutment against the vessel wall. When this occurs, a change in the light intensity signal results with a triggering of the light intensity alarm. Distinguishing a "desaturation reading" as a result of a change in position of the catheter tip from a pathologic desaturation can be problematic. Slight repositioning of the catheter or of the patient's head may be all that is needed to achieve an acceptable light signal. It is recommended that because of the above concerns, cerebral oximetry catheters be routinely calibrated to a cooximeter control.
It should be emphasized that SjVO 2 is a measure of global cerebral oxygenation and is not particularly sensitive to small areas of focal ischemia. Accordingly, the likelihood of a false negative value during an episode of focal ischemia is dependent on the area of ischemia and the capacity of the surrounding "normal" brain tissue to mask or average-out the ischemic tissue. In addition, the recommendation regarding which jugular vein to cannulate is not clear. As 70% of the cerebral venous blood drains via the ipsilateral jugular veins, some clinicians advocate cannulating at the side of injury. However, in the case of diffuse cerebral injury, most clinicians would monitor the right side, as it is commonly dominant, whereas some clinicians would advocate monitoring the side of dominant flow in all situations (see Which Side Should be Monitored?). More study is needed to definitively determine if there is an optimal side for SjVO 2 monitoring.
Clinical Factors Altering SjVO 2
Many factors affect the relationship of CMRO 2 and oxygen delivery (see Figure 4) . CBF can be decreased by head injury, thromboembolism, intracranial hypertension, hypotension, hyperventilation, or vasospasm. If CMRO 2 remains constant or increases under these conditions, SjVO 2 will decrease. Arterial hypoxia and increased CMRO 2 (e.g., febrile illness, seizures) can also result in SjVO 2 desaturation.
Causes of increased SjVO 2 and luxuriant oxygenation are described in Figure 4 . Correct interpretation of increased SjVO 2 requires confirmation that the catheter tip is at the jugular bulb. Reduced CMRO 2 (e.g., hypothermia, sedatives), increased CBF, pathologic arterial-venous communications, and brain death may result in increased SjVO 2 .
Clinical Utility of SjVO 2 Monitoring-Overview
Jugular venous oximetry is most often used in patients with head injuries for neurosurgical procedures and for cardiovascular procedures.
Head Injury
In the setting of head injury, SjVO 2 monitoring provides an early diagnosis of ischemia resulting from either intracranial or systemic causes (42) (43) (44) (45) (46) (47) (48) (49) . Moreover, SjVO 2 monitoring may be useful to guide decisions for optimizing hyperventilation therapy (43, 44, 48, 50, 51) , guiding fluid management and oxygenation (43, 51, 52) , optimizing perfusion pressure (53-55), and detecting arterial-venous fistulas (56, 57) . Used with a transcranial Doppler monitor, SjVO 2 can help discern between hyperemia and vasospasm. With high flow velocity detected by transcranial Doppler, SjVO 2 is increased during hyperemia and normal or low if cerebral vasospasm is present.
Barbiturate-induced cerebral metabolic suppression and induced hyperventilation are examples of two therapies for head injury that may be guided by SjVO 2 monitoring. Cruz (58) identified a group of headinjured patients who responded to pentobarbital with a decrease in SjVO 2 . It was hypothesized that the vasoconstrictive effect of barbiturates resulted in increased cerebrovascular resistance and oligemic cerebral hypoxia in these patients.
Routine hyperventilation after traumatic brain injury is not currently recommended (45). Rather, contemporary guidelines recommend "optimal hyperventilation" guided by SjVO 2 monitoring, thus identifying those head-injured patients with the potential for an ischemic response to hypocarbia (45). Moreover, SjVO 2 monitoring is also useful in evaluating prognosis for head-injured patients (59) . A strategy for management of low SjVO 2 occurring after head injury is detailed in Figure 3 .
Cardiovascular and Neurologic Surgery
Neurologic dysfunction is not uncommon after cardiac surgery with cardiopulmonary bypass and is attributed to the adverse effects of nonphysiologic modes of perfusion (60) . A particularly critical period concerns rewarming after hypothermic cardiopulmonary bypass. Rewarming has been related to frequent SjVO 2 desaturations which are associated with increased postoperative neurocognitive deficits (61) (62) (63) . It has been suggested that SjVO 2 monitoring may have (66) . They demonstrated that the SjVO 2 catheter could be placed quickly and detect frequent critical episodes of SjVO 2 desaturation that would otherwise have been untreated. During intracranial aneurysm surgery, SjVO 2 monitoring has been used to determine the minimal blood pressure that should be maintained to avoid hypoperfusion (67) .
Systemic versus Jugular versus Cerebral Oxygen Saturation
The possibility of using systemic mixed venous oxygenation as a surrogate of SjVO 2 to assess cerebral oxygenation has been studied. Given that the brain receives approximately 15% of the total cardiac output and that it extracts a greater fraction of oxygen from arterial blood than do other organs, it does not seem logical that systemic mixed venous oxygenation would be a reliable marker of cerebral oxygenation. Indeed, the lack of an association between systemic mixed venous oxygen and SjVO 2 has been validated with limited studies (34,68 -70) .
A concept with some promise is the potential for near-infrared spectroscopy (NIRS), a continuous, noninvasive monitor of brain oxygenation at the tissue level, to correlate with SjVO 2 as a measure of cerebral oxygen use. Presently, NIRS methods in adults are suspect primarily because of the inadequate predictability of extracerebral tissue to affect the NIRS signal, changes in arteriovenous partitioning, algorithm limitations, and variations in optical path length. It is likely that future advances in NIRS technology will result in a better understanding of these effects, with application of real-time correction factors. At this time, the data do not support a correlation between SjVO 2 and NIRS when assessing cerebral oxygen saturation in adults (71, 72) .
Despite the limitations of SjVO 2 monitoring, there is no better, commercially available, continuous, relatively low-cost, bedside monitor to assess the adequacy of cerebral oxygenation. Jugular venous oxygenation provides information on global brain oxygenation and is recommended in the treatment of patients with head injury, especially those receiving hyperventilation therapy.
Jugular venous oxygen monitoring is often performed in conjunction with other monitoring and imaging techniques and provides early detection of cerebral ischemia that might otherwise go unrecognized. However, the question should be asked: Do clinical decisions impacted by SjVO 2 data effect patient outcome? Although there appears to be a correlation between episodes of SjVO 2 desaturation and poor neurologic outcome, the impact of decisions influenced by SjVO 2 data and their effect on long-term cerebral function has yet to be proven.
